<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高解释</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250323161122<description>心血管高额外版：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250323161122" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>太阳，2025年3月23日20:11:23 +0000</lastbuilddate><pubDate> Sat, 22 Mar 2025 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>在2015年至2023年之间，现实世界实践中冠状动脉管理决策的变化：最逃避/BSE-NSTEP观察性研究的见解</title><link/>https://pubmed.ncbi.nlm.nih.gov/40119705/？ 08114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description>结论：冠状动脉管理途径在英国发生了变化，中等缺血的患者正在接受冠状动脉血管造影，但是，冠状动脉干预率没有变化，表明压力超声心动图用于改善患者的侵入性程序，同时将未来的参考量减小。对患者有任何影响... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur J Cardiovasc成像。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：评估更新的临床准则和文献对正在进行压力超声心动图的患者的管理的现实影响，以评估国家卫生服务范围内诱导性缺血。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：在2015  -  2023年之间，共有32名英国医院的13,819名患者在两个阶段中分析了应力超声心动图：第1阶段（2015-2020）和第2阶段（2020-2023）（2020-2023）。性别分布在跨阶段保持相似。在正压力超声心动图之后，侵入性的血管造影量（p &lt;0.01）似乎是归因于现代性缺血的患者的管理变化（3-4个段）中心的大多数证据执行更高量的应力超声心动图。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：冠状动脉管理途径在英国发生了变化，中等缺血的患者正在接受冠状动脉血管造影，但是，冠状动脉干预率没有变化，表明压力超声心动图用于改善患者的侵入性程序，同时将未来的参考量减小。是否对患者预后的任何影响。</p><p style="color: lightgray"> PMID <a href=https://doi.org/10.1093/ehjci/jeaf099>：</a> <a href="https://pubmed.ncbi.nlm.nih.gov/40119705/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40119705</a> |</p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40119705</guid><pubDate> Sat, 22 Mar 2025 06:00:00 -0400</pubDate><dc:creator>凯西·约翰逊</dc:creator><dc:creator>塞缪尔·克拉斯纳（Samuel Krasner）</dc:creator><dc:creator>威廉·伍德沃德</dc:creator><dc:creator>艾玛·毛</dc:creator><dc:creator>Annabelle McCourt</dc:creator><dc:creator>卡梅隆·迪克里尔（Cameron Dockerill）</dc:creator><dc:creator>卡特林·巴尔克豪森（Katrin Balkhausen）</dc:creator><dc:creator> Badrinathan Chandrasekaran</dc:creator><dc:creator> Attila Kardos</dc:creator><dc:creator> Nikant Sabharwal</dc:creator><dc:creator> Soroosh Firozan</dc:creator><dc:creator> Rizwan Sarwar</dc:creator><dc:creator> Roxy高级</dc:creator><dc:creator>Rajan Sharma</dc:creator><dc:creator>肯尼斯·黄</dc:creator><dc:creator>丹尼尔·X奥古斯丁</dc:creator><dc:creator>玛丽亚·帕顿（Maria Paton）</dc:creator><dc:creator>杰米·奥德里斯科尔（Jamie O&#39;Driscoll）</dc:creator><dc:creator>大卫·奥克斯伯勒（David Oxborough）</dc:creator><dc:creator>基思·皮尔斯</dc:creator><dc:creator>肖恩·罗宾逊</dc:creator><dc:creator>詹姆斯·威利斯</dc:creator><dc:creator>保罗·莱森（Paul Leeson）</dc:creator><dc:creator> Evarest/BSE-NSTEP研究人员</dc:creator><dc:date>2025-03-22</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>在2015年至2023年之间，现实世界实践中冠状动脉管理决策的变化：最逃避/BSE-NSTEP观察性研究的见解</dc:title><dc:identifier>PMID：40119705</dc:identifier><dc:identifier> doi：10.1093/ehjci/jeaf099</dc:identifier></item><item><title>答：在急性胸痛的情况下，不常见的心电图图案</title><link/>https://pubmed.ncbi.nlm.nih.gov/40118096/？ 08114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR J急性Cardiovasc Care。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID <a href=https://doi.org/10.1093/ehjacc/zuaf020>：</a> <a href="https://pubmed.ncbi.nlm.nih.gov/40118096/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40118096</a> |</p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40118096</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator>古尔巴丁·穆夫蒂（Gulbadin Mufti）</dc:creator><dc:creator> Shahid H Shali</dc:creator><dc:creator>一个沙赫尔·艾哈迈德（Shaheer Ahmed）</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>答：在急性胸痛的情况下，不常见的心电图图案</dc:title><dc:identifier>PMID：40118096</dc:identifier><dc:identifier> doi：10.1093/ehjacc/zuaf020</dc:identifier></item><item><title>蛋白质组和磷蛋白酶跨小鼠组织和大脑区域的营业额地图集</title><link/>https://pubmed.ncbi.nlm.nih.gov/40118046/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description>了解不同的哺乳动物组织中的蛋白质是生物学的核心，蛋白质丰度，翻译后的修饰（例如磷酸化）是确定组织特异性蛋白质的关键因素八只小鼠的磷岩... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月14日， <b>Cell</b> 。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">了解不同的哺乳动物组织中的蛋白质是生物学的核心，蛋白质丰度，翻译后的修饰（例如磷酸化）是确定组织特异性蛋白质的关键因素使用晚期蛋白质组织和稳定的同位素标记中的八个小鼠组织和各种大脑区域。蛋白质，例如tau和α-核蛋白。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40118046/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40118046</a> <a href=https://doi.org/10.1016/j.cell.2025.02.021>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40118046</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Wenxue li</dc:creator><dc:creator> Abhijit Dasgupta</dc:creator><dc:creator> Ka Yang</dc:creator><dc:creator> Shisheng Wang</dc:creator><dc:creator> Nisha Hemandhar-kumar</dc:creator><dc:creator> Surendhar R Chepyala</dc:creator><dc:creator>杰伊·M·亚布罗（Jay M Yarbro）</dc:creator><dc:creator> Zhenyi Hu</dc:creator><dc:creator> Barbora Salovska</dc:creator><dc:creator> Eugenio f fornasiero</dc:creator><dc:creator> Junmin Peng</dc:creator><dc:creator> Yansheng Liu</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>细胞</dc:source><dc:title>蛋白质组和磷蛋白酶跨小鼠组织和大脑区域的营业额地图集</dc:title><dc:identifier>PMID：40118046</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.021</dc:identifier></item><item><title>快照：人类精子界面蛋白</title><link/>https://pubmed.ncbi.nlm.nih.gov/40118033/？ 08114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description>人类受精是一个复杂的，高度调节的过程，涉及精子和卵之间的分子相互作用，最终在配子机制的融合中，在小鼠的融合中融合了基因破坏。 ot，打开或下载... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月<b>2025</b>日； 188（6）：1746-1746.e1。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">人类受精是一个复杂的，高度调节的过程，涉及精子和卵之间的分子相互作用，最终在配子机制的融合中，在小鼠的融合中融合了基因破坏。 ot，打开或下载PDF。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40118033/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40118033</a> <a href=https://doi.org/10.1016/j.cell.2025.01.001>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40118033</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator>艾米丽·福斯特（Emily Forster）</dc:creator><dc:creator> Xinyin Wang</dc:creator><dc:creator> Abenan Thayaparan</dc:creator><dc:creator>杰弗里·李（Jeffrey E Lee）</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>细胞</dc:source><dc:title>快照：人类精子界面蛋白</dc:title><dc:identifier>PMID：40118033</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.01.001</dc:identifier></item><item><title>探索植物微生物组：爬山作物的途径</title><link/>https://pubmed.ncbi.nlm.nih.gov/40118032/？ 08114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description>但是，在绿色革命期间，半矮人的作物变化和肥料的产量促进了粮食和粮食安全。 “气候智能农作物” </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月2025<b>日</b>； 188（6）：1469-1485</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">但是，在绿色革命期间，半矮人的作物变化和肥料的产量促进了粮食和粮食安全。 “气候智能Crops&quot; that improve yield and reduce negative impacts on the environment. Our proposed framework integrates plant genotype, root exudates, and microbes to optimize nutrient cycling, improve stress resilience, and expedite carbon sequestration. Integrating unselected ecological traits into crop breeding can promote agricultural sustainability, illuminating the next between plant genetics and ecosystem functioning.</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40118032/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40118032</a> <a href=https://doi.org/10.1016/j.cell.2025.01.035>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40118032</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> an-hui ge</dc:creator><dc:creator> Ertao Wang</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>细胞</dc:source><dc:title>探索植物微生物组：爬山作物的途径</dc:title><dc:identifier>PMID：40118032</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.01.035</dc:identifier></item><item><title>使用MERS相关的冠状病毒和Spilover风险的全球监视和对策</title><link/>https://pubmed.ncbi.nlm.nih.gov/40118031/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description>在本期的细胞中发表的三项研究表明，多个与MERS相关的冠状病毒（MERSR-COV）使用ACE2，而不是典型的Merbecovirus受体DPP4，用于细胞进入这些ACE2依赖的MERSR-COVS。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月<b>2025</b>日。188（6）：1465-1468。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">在本期的细胞中发表的三项研究表明，多个与MERS相关的冠状病毒（MERSR-COV）使用ACE2，而不是典型的Merbecovirus受体DPP4，用于细胞进入这些ACE2依赖的MERSR-COVS。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40118031/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40118031</a> <a href=https://doi.org/10.1016/j.cell.2025.02.004>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40118031</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Shibo Jiang</dc:creator><dc:creator>风扇吴</dc:creator><dc:date>2025-03-21</dc:date><dc:source>细胞</dc:source><dc:title>使用MERS相关的冠状病毒和Spilover风险的全球监视和对策</dc:title><dc:identifier>PMID：40118031</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.004</dc:identifier></item><item><title>线粒体疾病中的小分子缺氧治疗</title><link/>https://pubmed.ncbi.nlm.nih.gov/40118030/？ 8114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description>在这个细胞的问题中，Blume等人提供了引人注目的理由，以追求小分子的药物科学优化，从而左移红细胞中的氧血红蛋白解离曲线，以试图诱导有效的慢性疾病和有效的疾病，以促进慢性组织和持续的疾病（Pmococtiant）。改善神经系统鼠标的结果... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月2025<b>年</b>。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">在这个细胞的问题中，Blume等人提供了引人注目的理由，以追求小分子的药物科学优化，从而左移红细胞中的氧血红蛋白解离曲线，以试图诱导有效的慢性疾病和有效的疾病，以促进慢性组织和持续的疾病（Pmococtiant）。改善神经系统Leigh综合征谱的小鼠模型中的结果。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40118030/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40118030</a> <a href=https://doi.org/10.1016/j.cell.2025.02.019>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40118030</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Marni J Falk</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>细胞</dc:source><dc:title>线粒体疾病中的小分子缺氧治疗</dc:title><dc:identifier>PMID：40118030</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.019</dc:identifier></item><item><title>超越生命和死亡：衰老中性粒细胞的最终货物</title><link/>https://pubmed.ncbi.nlm.nih.gov/40118029/？ 08114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description>中性粒细胞在整个生命周期中进行了多种介体，但主要与促炎的功能有关。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 3月<b>2025</b>日。188（6）：1460-1462。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">中性粒细胞在整个生命周期中进行了多种介体，但主要与促炎的功能有关。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40118029/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40118029</a> <a href=https://doi.org/10.1016/j.cell.2025.02.020>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40118029</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator>赖</dc:creator><dc:creator>伊曼纽尔·库克（Immanuel Kwok）</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>细胞</dc:source><dc:title>超越生命和死亡：衰老中性粒细胞的最终货物</dc:title><dc:identifier>PMID：40118029</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.020</dc:identifier></item><item><title> &lt;em>;流通期刊家族的亮点</title><link/>https://pubmed.ncbi.nlm.nih.gov/40117191/？ 08114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。2025年2月25日； 151（8）：568-573。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40117191/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40117191</a> <a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073856>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40117191</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:date> 2025-03-21</dc:date><dc:source>循环</dc:source><dc:title>&lt;em>;流通期刊家族的亮点</dc:title><dc:identifier>PMID：40117191</dc:identifier><dc:identifier> doi：10.1161/CirculationAha.125.073856</dc:identifier></item><item><title> 2024修订ESC临床实践指南建议的证据评分系统的修订ii：诊断测试和预测模型</title><link/>https://pubmed.ncbi.nlm.nih.gov/40116738/？ 08114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description>欧洲心脏病学社会（ESC）临床实践指南（CPG）的证据水平（CPG）对支持建议的证据的质量归类。委员会，第一个任务是... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025 3月21日：EHAF016。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">欧洲心脏病学社会（ESC）临床实践指南（CPG）的证据水平（CPG）对支持建议的证据的质量归类。委员会首先负责更新LOE评分系统以进行治疗和预防，并负责开发诊断和预测的LOE评分系统。 A代表了至少两个高质量研究的诊断能力的结论性证据B代表了一个高质量的证据或至少两个中等质量的研究。从至少一个或多个中等质量的外部验证研究中，有足够的预测能力在一个或多个派生研究中是暗示性的证据。但是，质量低或没有外部验证，或对低质量的推导研究。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40116738/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40116738</a> <a href=https://doi.org/10.1093/eurheartj/ehaf016>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40116738</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Emanuele di Angelantonio</dc:creator><dc:creator>丽莎·彭内尔（Lisa Pennells）</dc:creator><dc:creator> Magdy Abdelhamid</dc:creator><dc:creator> Victor Aboyans</dc:creator><dc:creator> Riccardo asteggiano</dc:creator><dc:creator> Jelenačelutkienė</dc:creator><dc:creator> Diederick E Grobbee</dc:creator><dc:creator>伯纳德·伊恩（Bernard iung）</dc:creator><dc:creator>彼得·尤尼</dc:creator><dc:creator>约翰·威廉·麦克维（John William McEvoy）</dc:creator><dc:creator> Amina Rakisheva</dc:creator><dc:creator> Xavier Rossello</dc:creator><dc:creator>弗兰克·LJ Visseren</dc:creator><dc:creator> Colin Baigent</dc:creator><dc:creator> EVA B PRESCOTT</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>2024修订ESC临床实践指南建议的证据评分系统的修订ii：诊断测试和预测模型</dc:title><dc:identifier>PMID：40116738</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf016</dc:identifier></item><item><title> 2024修订ESC临床实践指南建议的证据分级系统的修订i：治疗和预防</title><link/>https://pubmed.ncbi.nlm.nih.gov/40116721/？ 08114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description> ESC临床实践指南的证据水平（LOE）的质量支持了建议的质量，目前的分类学并未完全考虑确定此类建议的最佳研究设计，因此，临床实践指南委员会任命了两个独立的临床专家。治疗的评分系统和... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月21日：EHAF009。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> ESC临床实践指南的证据水平（LOE）的质量支持了建议的质量，目前的分类学并未完全考虑确定此类建议的最佳研究设计，因此，临床实践指南委员会任命了两个独立的临床专家。治疗和预防的评分系统，第二个负责诊断和预测的LOE等级系统。荟萃分析（例如，用于优势的p &lt;.005）。在非劣质性，等效性和危害的情况下，定义了大量证据，以示例B1和B1的差异，这是≥1的频率，或者是A的差异。 （例如，p &lt;.05的优势水平）B2有限的证据有限，有限的非随机研究，仔细控制了主要的偏见来源，或者是对较小的，能力不足的RCT的荟萃分析。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40116721/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40116721</a> <a href=https://doi.org/10.1093/eurheartj/ehaf009>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40116721</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator>彼得·尤尼</dc:creator><dc:creator>Sotiris Antonio</dc:creator><dc:creator> Elena Arbelo</dc:creator><dc:creator> Sergio Buccheri</dc:creator><dc:creator> Maja Cikes</dc:creator><dc:creator> Bruno r da Costa</dc:creator><dc:creator>劳伦特·福希（Laurent Fauchier）</dc:creator><dc:creator>克里斯·P大风</dc:creator><dc:creator>西格伦·哈尔沃森（Sigrun Halvorsen）</dc:creator><dc:creator> Stefan James</dc:creator><dc:creator> Konstantinos C Koskinas</dc:creator><dc:creator> Dipak Kotecha</dc:creator><dc:creator> ULF Landmesser</dc:creator><dc:creator>罗勒斯·刘易斯</dc:creator><dc:creator>maja-lisaLøchen</dc:creator><dc:creator> Jens Cosedis Nielsen</dc:creator><dc:creator> XavierRosselló</dc:creator><dc:creator> Ilonca Vaartjes</dc:creator><dc:creator> EVA B PRESCOTT</dc:creator><dc:creator> Colin Baigent</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>2024修订ESC临床实践指南建议的证据分级系统的修订i：治疗和预防</dc:title><dc:identifier>PMID：40116721</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf009</dc:identifier></item><item><title>评估2024年对欧洲心脏病学会指南的证据评分系统的修订</title><link/>https://pubmed.ncbi.nlm.nih.gov/40116710/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025 3月21日：EHAF102：10.1093/Eurheartj/ehaf102。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID <a href=https://doi.org/10.1093/eurheartj/ehaf102>：</a> <a href="https://pubmed.ncbi.nlm.nih.gov/40116710/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40116710</a> |</p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40116710</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator>斯蒂芬·温德克（Stephan Windecker）</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>评估2024年对欧洲心脏病学会指南的证据评分系统的修订</dc:title><dc:identifier>PMID：40116710</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf102</dc:identifier></item><item><title>心脏病学领导者：克里斯蒂娜·巴索（Cristina Basso）</title><link/> https://pubmed.ncbi.nlm.nih.gov/40116225/？ 08114047＆ff = 20250323161122＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025 3月21日：EHAF104：10.1093/Eurheartj/ehaf104。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40116225/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40116225</a> <a href=https://doi.org/10.1093/eurheartj/ehaf104>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40116225</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator>朱迪思·奥兹坎（Judith Ozkan）</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>心脏病学领导者：克里斯蒂娜·巴索（Cristina Basso）</dc:title><dc:identifier> PMID：40116225</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf104</dc:identifier></item><item><title>复兴天鹅：介绍芝加哥血液动力学论坛</title><link/>https://pubmed.ncbi.nlm.nih.gov/40116016/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> CIRC HEART失败。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40116016/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40116016</a> <a href=https://doi.org/10.1161/CIRCHEARTFAILURE.124.012725>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40116016</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator>马克·贝尔金</dc:creator><dc:creator>詹妮弗（Jennifer）是一个牛仔</dc:creator><dc:creator>Marat Fudim</dc:creator><dc:creator>瑞安·J·特德福德（Ryan J Tedford）</dc:creator><dc:creator>乔纳森·格林斯坦（Jonathan Grinstein）</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>循环</dc:source><dc:title>复兴天鹅：介绍芝加哥血液动力学论坛</dc:title><dc:identifier>PMID：40116016</dc:identifier><dc:identifier> doi：10.1161/circheartfailure.124.012725</dc:identifier></item><item><title> 3D超声心动图和CMR成像，用于评估右心室功能和三尖瓣反流严重程度</title><link/>https://pubmed.ncbi.nlm.nih.gov/40116010/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description>结论：3DE提供了与CMR相当的TR严重性的准确评估。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> CIRC CARDIOVASC成像。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：Tricuspid反流（TR）与死亡率增加有关，并且由于成像方式的限制而经常被诊断，而常规的二维超声心动图（2DE）则经常与心脏磁共振成像（CMR）的分类相关，但在跨性别范围中均未分类。跨成像的方案因此，这项研究提供了所有3个成像模式（2DE，3DE和CMR）的模式比较，以评估TR的严重性，并提出使用CMR进行适应的5级分级方案。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在2个队列中分析了144例症状性TR：来自慕尼黑大学医院的派生队列（n = 91），并从心脏中心进行验证（n = 53）。 Ated。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在派生队列中（中位年龄为66％），TR严重性高度与CMR高度相关（在1年级差异内有87％的一致性），与2DE相比，与CMR相比，相当于<i>cmr</i>的2DE（68％）与CMR相比，准确率最低（34.5％; <i>p</i> = 0.005）频繁地高估了TR的严重性与CMR相比，与2DE相比<i>，</i> TR的严重程度显着频繁（21％vers 56％； <i>P</i> &lt;0.001） ATED，显示出可比的结果在派生和验证队列中。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：3DE提供了与CMR相当的TR严重性的准确评估。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40116010/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40116010</a> <a href=https://doi.org/10.1161/CIRCIMAGING.124.017638>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40116010</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Philipp M Doldi</dc:creator><dc:creator>路德维希·韦克巴赫</dc:creator><dc:creator>尼古拉·芬克（Nicola Fink）</dc:creator><dc:creator>卢卡斯·斯托尔兹（Lukas Stolz）</dc:creator><dc:creator> Cecilia ennin</dc:creator><dc:creator>朱利安·丁克尔（Julien Dinkel）</dc:creator><dc:creator>菲利普·卢兹（Philipp Lurz）</dc:creator><dc:creator> Holger Thiele</dc:creator><dc:creator>丽贝卡·哈恩（Rebecca Hahn）</dc:creator><dc:creator> JoãoLCavalcante</dc:creator><dc:creator>克里斯蒂安·贝斯勒（Christian Besler）</dc:creator><dc:creator>约尔格·豪斯莱特（JörgHausleiter）</dc:creator><dc:date> 2025-03-21</dc:date><dc:source>循环</dc:source><dc:title>3D超声心动图和CMR成像，用于评估右心室功能和三尖瓣反流严重程度</dc:title><dc:identifier>PMID：40116010</dc:identifier><dc:identifier> doi：10.1161/cimimaging.124.017638</dc:identifier></item><item><title>矛盾的低流量，低梯度严重主动脉狭窄的严重二尖瓣反流</title><link/>https://pubmed.ncbi.nlm.nih.gov/40116009/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description>结论：低梯度，低梯度的严重主动脉狭窄与不良后果和独特的左心室重塑有关，主动脉瓣替换会改善所有MR等级的生存，在严重MR中的影响更大。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Cardiovasc Imaging。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：矛盾的低梯度狭窄的患者暴露于低骨流量（Q），同时保持左心室射血分数（MR）的左心室射血分数（MR）也会导致低流动性的诊断和管理重点。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：来自机构回波数据库的数据确定了1189例调整后的主动脉瓣狭窄（主动脉瓣面积≤1.0cm <sup>2</sup> ），较低的跨积极梯度（平均梯度&lt;40 mm Hg），保留了左心室偏射分数（≥50％），并确认了较低的速率（Q;亚组基于MR严重程度（严重和非严重性）。临床结果包括全因死亡率，主动脉瓣置换，心力衰竭住院和综合结果。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在严重的MR组中，患者的流量较低，左心室尺寸增加，而偏心肥大的模式与Nonevere MR相比（ <i>n</i> = 1109）（ <i>n</i> = 1109）。死亡率风险（危险比率为1.43； <i>p</i> = 0.011）和综合<i>结果</i>（危险比，1.64； <i>p</i> <i>&lt;</i> <sub>0.001</sub> ）显着降低了每个MR度的死亡率。 。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：低梯度，低梯度的严重主动脉狭窄与不良后果和独特的左心室重塑有关，主动脉瓣替换会改善所有MR等级的生存，在严重MR中的影响更大。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40116009/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40116009</a> <a href=https://doi.org/10.1161/CIRCIMAGING.124.017598>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40116009</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Shani Dahan</dc:creator><dc:creator>雅各布·达尔·比安科（Jacob Dal-Bianco）</dc:creator><dc:creator> Ygal Plakht</dc:creator><dc:creator> Mayoran Namasivayam</dc:creator><dc:creator> Romain Capoulade</dc:creator><dc:creator>新Zeng</dc:creator><dc:creator> Jonathan J Passeri</dc:creator><dc:creator> Evin Yucel</dc:creator><dc:creator>迈克尔·皮卡德（Michael H Picard）</dc:creator><dc:creator>罗伯特·莱文（Robert A Levine）</dc:creator><dc:creator>朱迪吊死</dc:creator><dc:date>2025-03-21</dc:date><dc:source>循环</dc:source><dc:title>矛盾的低流量，低梯度严重主动脉狭窄的严重二尖瓣反流</dc:title><dc:identifier>PMID：40116009</dc:identifier><dc:identifier> doi：10.1161/cimimaging.124.017598</dc:identifier></item><item><title>心绞痛和非刺激性冠状动脉患者心外膜冠状动脉痉挛的CT预测指标</title><link/>https://pubmed.ncbi.nlm.nih.gov/40116006/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description>结论：对于非冠状动脉冠状动脉的患者，使用CCTA进行非侵入性综合评估的预痉挛挑衅测试可能有助于识别患有VSA高风险的人。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> CIRC CARDIOVASC成像。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: Recent studies have shown that vasospastic angina (VSA) is associated with myocardial bridge (MB) and pericoronary adipose tissue inflammation. We aimed to investigate the clinical and coronary computed tomography angiographic (CCTA) features that could predict VSA in patients with angina and nonobstructive coronary arteries. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: We retrospectively studied patients with nonobstructive coronary arteries who underwent a spasm provocation test and CCTA within 3 months before the spasm provocation test. Pericoronary adipose tissue inflammation was evaluated using the fat attenuation index (FAI) of the proximal reference diameter and the inner 2 mm adipose tissue layer (FAI <sub>2mm</sub> ) from the vessel wall. Coronary plaques were qualitatively classified as noncalcified or calcified plaques in each vessel. In addition, MB was evaluated in the left descending artery. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: This study included 142 patients, with 55 (38.7%) diagnosed with VSA. Factors associated with VSA included male sex (74.5% versus 51.7%, <i>P</i> =0.01), smoking history (70.9% versus 52.9%, <i>P</i> =0.05), CCTA-defined MB (49.1% versus 28.7%, <i>P</i> =0.02), and FAI, especially FAI <sub>2mm</sub> in the right coronary artery-FAI <sub>2mm</sub> (-68.8 Hounsfield unit versus -74.0 Hounsfield unit, <i>P</i> &lt;0.01), as well as the presence of CCTA-defined mixed or noncalcified plaque anywhere in the coronary tree (65.5% versus 39.1%, <i>P</i> &lt;0.01). In a multivariable analysis, CCTA-defined MB (odds ratio, 2.23 [95% CI, 1.03-4.83]; <i>P</i> =0.04), right coronary artery-FAI <sub>2mm</sub> (odds ratio, 1.07 [95% CI, 1.02-1.12]; <i>P</i> &lt;0.01), and the presence of mixed or noncalcified plaque (odds ratio, 3.15 [95% CI, 1.45-6.80]; <i>P</i> &lt;0.01) were independently associated with VSA. A combination of CCTA-defined MB in the left descending artery, high right coronary artery-FAI <sub>2mm</sub> (≥-72.6 Hounsfield unit, median), and CCTA-defined mixed or noncalcified plaque in the coronary tree predicted VSA with a 75.0% probability, while the absence of all 3 factors precluded VSA with 95.6% probability. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: For patients with nonobstructive coronary arteries, a prespasm provocation test using a noninvasive comprehensive assessment with CCTA may help identify those at high risk for VSA.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40116006/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40116006</a> | DOI: <a href=https://doi.org/10.1161/CIRCIMAGING.124.017565>10.1161/CIRCIMAGING.124.017565</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40116006</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Takashi Mineo</dc:creator><dc:creator> Eisuke Usui</dc:creator><dc:creator> Yoshihisa Kanaji</dc:creator><dc:creator> Masahiro Hada</dc:creator><dc:creator> Tatsuhiro Nagamine</dc:creator><dc:creator> Hiroki Ueno</dc:creator><dc:creator> Kai Nogami</dc:creator><dc:creator> Mirei Setoguchi</dc:creator><dc:creator> Tomohiro Tahara</dc:creator><dc:creator> Tatsuya Sakamoto</dc:creator><dc:creator> Masahiro Hoshino</dc:creator><dc:creator> Tomoyo Sugiyama</dc:creator><dc:creator> Taishi Yonetsu</dc:creator><dc:creator> Tetsuo Sasano</dc:creator><dc:creator> Tsunekazu Kakuta</dc:creator><dc:date> 2025-03-21</dc:date><dc:source> Circulation. Cardiovascular imaging</dc:source><dc:title> CT Predictors of Epicardial Coronary Spasm in Patients With Angina and Nonobstructive Coronary Arteries</dc:title><dc:identifier> pmid:40116006</dc:identifier><dc:identifier> doi:10.1161/CIRCIMAGING.124.017565</dc:identifier></item><item><title> MRI-Extracellular Volume Fraction Versus Histological Amyloid Load in Cardiac Amyloidosis: The Importance of T2 Mapping</title><link/> https://pubmed.ncbi.nlm.nih.gov/40116000/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description> CONCLUSIONS: In patients with ATTRwt-CM and prolonged T2, MRI-ECV did not accurately reflect histological amyloid load. Our findings underscore the need for a multiparametric imaging approach, combining both ECV and T2 mapping, to better characterize myocardial tissue in patients with ATTRwt-CM, and further prospective research in larger and more diverse cohorts is needed to validate our results. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Cardiovasc Imaging. 2025 Mar 21:e017427. doi: 10.1161/CIRCIMAGING.124.017427. Online ahead of print.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: MRI-derived myocardial extracellular volume fraction (ECV) is elevated in the presence of fibrosis, amyloid deposition, inflammation and edema. In patients with cardiac amyloidosis and prolonged T2 due to concomitant inflammation or edema, MRI-ECV may not correctly reflect histological amyloid load. The authors sought to determine whether MRI-ECV can accurately reflect histological amyloid load in 2 groups of patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM), with and without T2 prolongation. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: This retrospective study included consecutive patients with ATTRwt-CM who underwent endomyocardial biopsy and cardiac MRI from March 2017 to October 2021 for initial evaluation of ATTRwt-CM. We measured MRI-ECV and T2, and evaluated correlation between MRI-ECV and amyloid load from endomyocardial biopsy by means of Pearson correlation analysis. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Of 44 patients (mean age, 75±6 years [SD]; 40 men), 24 showed T2 prolongation (T2≥50 milliseconds). All specimens obtained by endomyocardial biopsy were suitable for analysis. The interval between endomyocardial biopsy and cardiac MRI examination was a median of 3 days (interquartile range, 2-4). In the absence of T2 prolongation due to increased water content, MRI-ECV and amyloid load showed a moderately significant correlation (Spearman ρ=0.50, <i>P</i> =0.03). However, in the presence of T2 prolongation, there was no significant correlation between MRI-ECV and amyloid load (Spearman ρ=-0.05, <i>P</i> =0.83). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: In patients with ATTRwt-CM and prolonged T2, MRI-ECV did not accurately reflect histological amyloid load. Our findings underscore the need for a multiparametric imaging approach, combining both ECV and T2 mapping, to better characterize myocardial tissue in patients with ATTRwt-CM, and further prospective research in larger and more diverse cohorts is needed to validate our results.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40116000/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40116000</a> | DOI: <a href=https://doi.org/10.1161/CIRCIMAGING.124.017427>10.1161/CIRCIMAGING.124.017427</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40116000</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Masafumi Kidoh</dc:creator><dc:creator> Seitaro Oda</dc:creator><dc:creator> Seiji Takashio</dc:creator><dc:creator> Mami Morioka</dc:creator><dc:creator> Naoto Kuyama</dc:creator><dc:creator> Tetsuya Oguni</dc:creator><dc:creator> Takeshi Nakaura</dc:creator><dc:creator> Yasunori Nagayama</dc:creator><dc:creator> Yasuhiro Izumiya</dc:creator><dc:creator> Kenichi Tsujita</dc:creator><dc:creator> Toshinori Hirai</dc:creator><dc:date> 2025-03-21</dc:date><dc:source> Circulation. Cardiovascular imaging</dc:source><dc:title> MRI-Extracellular Volume Fraction Versus Histological Amyloid Load in Cardiac Amyloidosis: The Importance of T2 Mapping</dc:title><dc:identifier> pmid:40116000</dc:identifier><dc:identifier> doi:10.1161/CIRCIMAGING.124.017427</dc:identifier></item><item><title> Physical Activity Reduction in Patients Following ICD Therapy</title><link/> https://pubmed.ncbi.nlm.nih.gov/40115999/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Arrhythm Electrophysiol. 2025 Mar 21:e013196. doi: 10.1161/CIRCEP.124.013196. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40115999/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40115999</a> | DOI: <a href=https://doi.org/10.1161/CIRCEP.124.013196>10.1161/CIRCEP.124.013196</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40115999</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Michael Christof</dc:creator><dc:creator> Alex Page</dc:creator><dc:creator> Spencer Rosero</dc:creator><dc:creator> Valentina Kutyifa</dc:creator><dc:date> 2025-03-21</dc:date><dc:source> Circulation. Arrhythmia and electrophysiology</dc:source><dc:title> Physical Activity Reduction in Patients Following ICD Therapy</dc:title><dc:identifier> pmid:40115999</dc:identifier><dc:identifier> doi:10.1161/CIRCEP.124.013196</dc:identifier></item><item><title> Performance of AlphaMissense and Other In Silico Predictors to Determine Pathogenicity of Missense Variants in Sarcomeric Genes</title><link/> https://pubmed.ncbi.nlm.nih.gov/40115995/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Genom Precis Med. 2025 Mar 21:e004922. doi: 10.1161/CIRCGEN.124.004922. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40115995/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40115995</a> | DOI: <a href=https://doi.org/10.1161/CIRCGEN.124.004922>10.1161/CIRCGEN.124.004922</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40115995</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Mario Ruiz</dc:creator><dc:creator> Juan Pablo Ochoa</dc:creator><dc:creator> Candela Migoyo-Bettoni</dc:creator><dc:creator> Jorge de la Barrera</dc:creator><dc:creator> Alba Delrio-Lorenzo</dc:creator><dc:creator> Manuel A Fernández-Rojo</dc:creator><dc:creator> Ines Martinez-Martin</dc:creator><dc:creator> Jorge Alegre-Cebollada</dc:creator><dc:creator> Enrique Lara-Pezzi</dc:creator><dc:creator> Fatima Sanchez-Cabo</dc:creator><dc:creator> Pablo Garcia-Pavia</dc:creator><dc:date> 2025-03-21</dc:date><dc:source> Circulation. Genomic and precision medicine</dc:source><dc:title> Performance of AlphaMissense and Other In Silico Predictors to Determine Pathogenicity of Missense Variants in Sarcomeric Genes</dc:title><dc:identifier> pmid:40115995</dc:identifier><dc:identifier> doi:10.1161/CIRCGEN.124.004922</dc:identifier></item><item><title> National Organ Procurement and Transplant Network Heart Allocation Policy: 6 Years Later</title><link/> https://pubmed.ncbi.nlm.nih.gov/40115988/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250323161122&amp;v=2.18.0.post9+e462414<description> In 2014, the Organ Procurement and Transplant Network began reappraisal of the United States heart transplant allocation policy. Driven by ongoing discordance between organ supply and demand, high waitlist mortality, and increasing exception requests, the Thoracic Committee radically redesigned the priority scheme and drafted a 6-tiered algorithm, included durable device complications into policy, expanded broader sharing, and increased the number of mandatory listing variables to develop a... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Heart Fail. 2025 Mar 21:e011631. doi: 10.1161/CIRCHEARTFAILURE.124.011631. Online ahead of print.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> In 2014, the Organ Procurement and Transplant Network began reappraisal of the United States heart transplant allocation policy. Driven by ongoing discordance between organ supply and demand, high waitlist mortality, and increasing exception requests, the Thoracic Committee radically redesigned the priority scheme and drafted a 6-tiered algorithm, included durable device complications into policy, expanded broader sharing, and increased the number of mandatory listing variables to develop a future heart allocation score. This became the 2018 New Heart Allocation Policy. Changes in allocation priority have resulted in a significant increase in the use of temporary mechanical circulatory support in waitlisted candidates with a concomitant decrease in the number of patients bridged to transplanted with durable left ventricular assist device support. The number of exception requests continues to increase, particularly for patients listed status 2 and for multiorgan transplants. Importantly, fewer patients are being delisted for clinical improvement, suggesting missed opportunities for recovery. The current review will critically evaluate the 2018 heart allocation policy 6 years later, briefly focusing on the history of heart allocation in the United States, the current and evolving algorithms for candidate prioritization including continuous distribution, the impact of technology and innovation on transplant rates and future policy development, and the ongoing regulatory oversight and governance changes in the Organ Procurement and Transplant Network.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40115988/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250323161122&v=2.18.0.post9+e462414">40115988</a> | DOI: <a href=https://doi.org/10.1161/CIRCHEARTFAILURE.124.011631>10.1161/CIRCHEARTFAILURE.124.011631</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40115988</guid><pubDate> Fri, 21 Mar 2025 06:00:00 -0400</pubDate><dc:creator> Lauren K Truby</dc:creator><dc:creator> Liviu Klein</dc:creator><dc:creator> Jane E Wilcox</dc:creator><dc:creator> Maryjane Farr</dc:creator><dc:date> 2025-03-21</dc:date><dc:source> Circulation. Heart failure</dc:source><dc:title> National Organ Procurement and Transplant Network Heart Allocation Policy: 6 Years Later</dc:title><dc:identifier> pmid:40115988</dc:identifier><dc:identifier> doi:10.1161/CIRCHEARTFAILURE.124.011631</dc:identifier></item></channel></rss>